Search

everythinglearnresearchcommunity

for

Search:↓

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Researchers found a new genetic mutation linked to a hair condition in a Japanese boy.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Frontal fibrosing alopecia can occur with lichen planus pigmentosus, needing careful diagnosis and treatment.

Men with male pattern baldness have higher levels of A-FABP, which might help in early detection.

Targeting LPA could help treat skin disorders.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

A specific mutation in PA-PLA1α causes abnormal hair growth.

Alitretinoin can effectively treat frontal fibrosing alopecia.

The protein FLCN is involved in cellular cleanup and is regulated by ULK1.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

A new genetic variant in the LIPH gene causes hair growth issues in a Chinese patient.

Certain microRNAs might help identify and understand Frontal Fibrosing Alopecia.

Some people with lichen planus pigmentosus might later develop frontal fibrosing alopecia.

Higher FABP4 levels may indicate more severe alopecia areata.

Higher FABP4 levels may help diagnose androgenetic alopecia early.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Blocking LFA-1 prevents hair loss in mice.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Tofacitinib significantly improved skin and hair conditions without side effects.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Inhibiting ALOX12 can help hair cuticle maturation by increasing S100A3 citrullination.

FFA patients have fewer melanocytes and thinner skin compared to others.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Certain genetic changes in the LSS gene cause a rare skin and hair condition.